National Register of Oesophageal Atresia

计划入组 1,460 人 · 首次发布于 2016 年 8 月 30 日

A Study of Patients Undergoing Surgical Treatment for Oesophageal Atresia

计划入组 50 人 · 首次发布于 2024 年 2 月 29 日

Swallowing, Feeding and Eating in Children Born With Oesophageal Atresia/Trache-oesophageal Fistula (OA/TOF)

计划入组 20 人 · 首次发布于 2019 年 12 月 3 日

Cellspan oesophageal implant (Biostage)

Gastro-Oesophageal Reflux Therapy (Nycomed)

Cellspan Esophageal Implant

Atreca, Inc.

United States

Atridia Pty Ltd.

Australia

Aprecia Pharmaceuticals, LLC

United States

Lab-Grown Oesophagus Successfully Restores Swallowing Function in Pigs, Human Trials Planned Within Five Years

Ipsen's Phase III BOLD Trial of Bylvay in Biliary Atresia Misses Primary Endpoint

Harvard Apparatus Regenerative Technology and Capital Institute of Pediatrics Collaborate on Esophageal Atresia Treatment